Research graph
References from Vibecotamab for measurable residual disease in acute myeloid leukemia and for myelodysplastic syndromes and chronic myelomonocytic leukemia after hypomethylating agent failure: a phase II study. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1002/ajh.26984
10.1002/ajh.26984 · 2023 · External reference
10.1056/nejmra1406184
10.1056/nejmra1406184 · 2015 · External reference
10.1038/s41408-024-01143-2
10.1038/s41408-024-01143-2 · 2024 · External reference
10.1182/blood.2025031480
10.1182/blood.2025031480 · External reference
Unresolved reference
2024 · External reference
10.1001/jamaoncol.2020.4600
10.1001/jamaoncol.2020.4600 · 2020 · External reference
10.1111/bjh.16857
10.1111/bjh.16857 · 2020 · External reference
10.1182/bloodadvances.2022009391
10.1182/bloodadvances.2022009391 · 2023 · External reference
10.1002/ajh.27482
10.1002/ajh.27482 · 2025 · External reference
10.1002/ajh.26698
10.1002/ajh.26698 · 2022 · External reference
10.1016/j.leukres.2021.106555
10.1016/j.leukres.2021.106555 · 2021 · External reference
10.1200/jco.2011.35.8135
10.1200/jco.2011.35.8135 · 2011 · External reference
10.1182/blood-2017-10-811729
10.1182/blood-2017-10-811729 · 2018 · External reference
10.1002/cncr.25247
10.1002/cncr.25247 · 2010 · External reference
Unresolved reference
2001 · External reference
10.3390/cancers11091358
10.3390/cancers11091358 · 2019 · External reference
10.1056/nejmoa1815105
10.1056/nejmoa1815105 · 2019 · External reference
10.1182/blood.v124.21.2316.2316
10.1182/blood.v124.21.2316.2316 · 2014 · External reference
10.1182/bloodadvances.2023010956
10.1182/bloodadvances.2023010956 · 2023 · External reference
10.1182/blood-2012-03-420489
10.1182/blood-2012-03-420489 · 2012 · External reference
10.1182/blood-2005-10-4149
10.1182/blood-2005-10-4149 · 2006 · External reference
10.1002/cyto.b.22140
10.1002/cyto.b.22140 · 2023 · External reference
10.5858/arpa.2025-0053-oa
10.5858/arpa.2025-0053-oa · 2025 · External reference
10.1016/0197-2456(96)00075-x
10.1016/0197-2456(96)00075-x · 1996 · External reference
10.1182/blood.2022016867
10.1182/blood.2022016867 · 2022 · External reference
10.1056/evidoa2200008
10.1056/evidoa2200008 · 2022 · External reference
10.1182/blood-2016-05-714030
10.1182/blood-2016-05-714030 · External reference
Unresolved reference
2023 · External reference
10.1182/blood-2025-2075
10.1182/blood-2025-2075 · 2025 · External reference
10.1016/j.leukres.2025.107692
10.1016/j.leukres.2025.107692 · 2025 · External reference
10.1186/s13045-022-01319-y
10.1186/s13045-022-01319-y · 2022 · External reference
10.3324/haematol.2018.207118
10.3324/haematol.2018.207118 · 2019 · External reference
10.1158/2159-8290.cd-22-0332
10.1158/2159-8290.cd-22-0332 · 2022 · External reference
10.1182/bloodadvances.2020002512
10.1182/bloodadvances.2020002512 · 2020 · External reference
10.1182/blood.2024027500
10.1182/blood.2024027500 · 2025 · External reference
10.1182/blood-2017-08-798322
10.1182/blood-2017-08-798322 · 2018 · External reference
10.3389/fimmu.2025.1627161
10.3389/fimmu.2025.1627161 · External reference
10.1126/scitranslmed.aaz0463
10.1126/scitranslmed.aaz0463 · 2020 · External reference
10.1016/s1470-2045(23)00674-5
10.1016/s1470-2045(23)00674-5 · 2024 · External reference
10.1056/nejmoa1815105
10.1056/nejmoa1815105 · 2019 · External reference
10.1182/blood-2014-04-566737
10.1182/blood-2014-04-566737 · 2014 · External reference
10.1182/blood.2020007732
10.1182/blood.2020007732 · 2021 · External reference
